Company profile for Chance Pharmaceuticals

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Chance Pharmaceuticals is a clinical-stage biopharmaceutical company committed to improving quality of life by developing treatments for respiratory and central nervous system disorders. The company specializes in creating innovative inhaled therapies, combining scientific research with advanced pulmonary drug delivery technologies. With its strong expertise and innovation-driven approach, Chance Pharmaceuticals has built a di...
Chance Pharmaceuticals is a clinical-stage biopharmaceutical company committed to improving quality of life by developing treatments for respiratory and central nervous system disorders. The company specializes in creating innovative inhaled therapies, combining scientific research with advanced pulmonary drug delivery technologies. With its strong expertise and innovation-driven approach, Chance Pharmaceuticals has built a diverse and promising product pipeline aimed at addressing significant unmet medical needs.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
China
Address
Address
Room 501, Building 18, Yinhai Kechuang Center, 501 Fucheng Road, Xiasha Street...
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/chance-pharma-announces-commercialization-agreement-with-huadong-medicine-for-innovative-respiratory-drug-cxg87-302579528.html

PR NEWSWIRE
09 Oct 2025

https://www.prnewswire.com/news-releases/chance-pharma-secures-new-funding-to-accelerate-development-of-innovative-inhalation-therapies-302402896.html

PR NEWSWIRE
17 Mar 2025

https://www.prnewswire.com/news-releases/chance-pharmaceuticals-and-acorda-therapeutics-announce-agreement-to-provide-inbrija-in-greater-china-301818081.html

PR NEWSWIRE
08 May 2023

https://www.globenewswire.com/news-release/2021/10/11/2311485/0/en/Chance-Pharmaceuticals-Secures-30-Million-Series-C-Funding-to-Advance-Innovative-Pipeline-and-Initiate-Additional-Business-Collaborations.html

GLOBENEWSWIRE
10 Oct 2021

https://www.globenewswire.com/news-release/2021/09/30/2305845/0/en/Hangzhou-Chance-Pharmaceuticals-Appoints-Guobao-Zhao-as-Senior-Vice-President.html

GLOBENEWSWIRE
29 Sep 2021

https://www.globenewswire.com/news-release/2021/02/09/2172351/0/en/Hangzhou-Chance-Pharmaceuticals-Expands-Pipeline-with-In-Licensing-of-AER901-from-Aerami-Therapeutics.html

GLOBENEWSWIRE
09 Feb 2021

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty